Premium
Immune‐Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple Sclerosis
Author(s) -
Bolte Fabian J.,
Schmidt Hartmut H.J.,
Schlevogt Bernhard
Publication year - 2021
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.31435
Subject(s) - alemtuzumab , medicine , gastroenterology , natalizumab , liver injury , glatiramer acetate , jaundice , multiple sclerosis , hepatitis , hepatitis c , nausea , autoimmune hepatitis , population , toxic hepatitis , vomiting , immunology , transplantation , environmental health